Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
The application of the rapidly evolving field of single-cell technologies like CyTOF and single-cell RNAseq is allowing identification of novel cell communities that are important in CVD. Based on recent and many ongoing studies we will be able to improve patient-at-risk identification and define new therapeutic strategies for treatment of disease.
Join the discussion during the 4th biennial Symposium of the ESC Working Group on Atherosclerosis and Vascular Biology organised just before the Frontiers in CardioVascular Biomedicine (FCVB) Congress.
Being a Member of the Working Group on Atherosclerosis & Vascular Biology is a pre-requisite to participate in the Symposium.
Join the Working Group
Membership is free.
When your membership application is completed, you will be able to register.
Semmelweis University, Basic Medical Center, Üllői út 26, Budapest, Hungary
First floor, room Beznak
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
Semmelweis University, Basic Medical Center
Üllői út 26
1085 Budapest , HU
Our mission: To reduce the burden of cardiovascular disease.
© 2020 European Society of Cardiology. All rights reserved.